Clinical Trial Update: LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS)

View source ↗

Summary

This is a completed clinical trial update for GERD patients in the LIFE NIS study, evaluating burden of disease using the GERD Impact Scale. Sponsored by AstraZ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: GERD | Status: COMPLETED